Effects of the neuraminidase inhibitor zanamivir on otologic manifestations of experimental human influenza

Journal of Infectious Diseases

Volumn 176, Issue 6, 1997, Pages 1417-1422

  Walker, J B ^a   Hussey, E K ^a   Treanor, J J ^a   Montalvo A , Jr ^a   Hayden, F G ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIALIDASE INHIBITOR; ZANAMIVIR;

ADULT; ANTIBODY TITER; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; HUMAN TISSUE; INFLUENZA VIRUS; INTRANASAL DRUG ADMINISTRATION; NORMAL HUMAN; OTITIS MEDIA; PRESSURE MEASUREMENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; VIRUS INFECTIVITY; VIRUS INHIBITION;

EID: 0030724941     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/514136     Document Type: Article

References (27)